Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccine, and tetanus vaccines, as well as genetic engineering of biological products. The company also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Metrics to compare | 301207 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301207PeersSector | |
---|---|---|---|---|
P/E Ratio | 56.2x | 35.8x | −0.5x | |
PEG Ratio | −0.75 | −0.16 | 0.00 | |
Price/Book | 1.9x | 2.5x | 2.6x | |
Price / LTM Sales | 10.0x | 7.3x | 3.3x | |
Upside (Analyst Target) | 30.4% | 0.1% | 43.5% | |
Fair Value Upside | Unlock | 9.2% | 6.3% | Unlock |